Joining forces to harness the full potential of therapies for life-threatening diseases
Partnerships are key to fuel our quest to innovative products that will enhance our pipeline, but also to identify the right commercial partners that will help us develop and commercialize our drug candidates. Based on our experience, we understand the creativity and challenges it takes to translate innovation into products. Celyad is looking to consider all opportunities with a strong scientific rationale in the field of immune-therapy regardless of the development stage.
Celyad announces new agreements with Celdara Medical and Dartmouth College
FDA grants Fast Track designation for Celyad’s ischemic heart failure therapy, C-Cure®
Want to see more?